v3.26.1
LUNAI BIOWORKS TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 01, 2026
Apr. 17, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Apr. 30, 2026
Apr. 26, 2026
Dec. 31, 2025
Share based compensation         $ 2,372,257      
Account payable         32,955      
Revenue     $ 250,000 250,000      
Investment in GMP Bio at fair value     388,000,000   388,000,000       $ 388,000,000
Lunai Bioworks, Inc [Member] | Series B Preferred Stock [Member]                  
Limited Liability Company (LLC) Preferred Unit, Issuance Value     12,500,000   12,500,000        
Investment in GMP Bio at fair value     $ 1,100,000   1,100,000        
Gain in the value         $ 300,000 $ 300,000      
Service Agreement [Member] | Intellectual Property [Member] | Lunai Bioworks, Inc [Member]                  
Share based compensation   $ 250,000              
Account payable related party   62,500              
Provisional patents amount   62,500              
Account payable   $ 125,000              
Merger Agreement [Member] | Lunai Bioworks, Inc [Member] | Series B Convertible Preferred Stock [Member]                  
Shares issued 8                
Cash proceeds $ 20,000,000                
Merger Agreement [Member] | Lunai Bioworks, Inc [Member] | Series B Preferred Stock [Member]                  
Shares issued 5                
Cash proceeds $ 12,500,000                
Merger Agreement [Member] | Lunai Bioworks, Inc [Member]                  
Ownership percentage               62.50%  
Minority interest percentage               37.50%  
Merger Agreement [Member] | Lunai Bioworks, Inc [Member] | Series B Preferred Stock [Member]                  
Ownership percentage 62.50%                
Asset Transfer Agreement [Member] | Lunai Bioworks, Inc [Member] | Series B Preferred Stock [Member]                  
Ownership percentage             10.00%